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Abbreviations 
ACSA Anatomical cross-sectional area 
AD Anterior deltoid  
ANOVA Analysis of variance 
BBL Biceps brachii long head 
BBS Biceps brachii short head 
BR Brachioradialis  
BRACH Brachialis  
EMG Electromyography 
iMVF Isometric maximal voluntary force 
MVC Maximum voluntary contraction 
MRI Magnetic resonance imaging 
Mmax Evoked supramaximal compound muscle action potential  
PM Pectoralis major  
RMS Root mean square 
RT Resistance training 
sEMG Surface electromyography 
Vm Muscle volume 
1-RM Single repetition maximum  
p Muscle fascicle pennation angle  
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ABSTRACT  
Purpose: Whilst skeletal muscle hypertrophy is considered an important adaptation to 1 
resistance training (RT) it has not previously been found to explain the inter-2 
individual changes in strength after RT. This study investigated the contribution of 3 
hypertrophy to individual gains in isometric, isoinertial and explosive strength after 4 
12 weeks of elbow flexor RT. Methods: Thirty-three previously untrained, healthy 5 
men (18-30 yr) completed an initial 3-wk period of elbow flexor RT (to facilitate 6 
neurological responses), followed by 6-wk no training, and then 12-wk elbow flexor 7 
RT. Unilateral elbow flexor muscle strength [isometric maximum voluntary force 8 
(iMVF), single repetition maximum (1-RM) and explosive force], muscle volume 9 
(Vm), muscle fascicle pennation angle (p) and normalized agonist, antagonist and 10 
stabilizer sEMG were assessed pre and post 12-wk RT. Results: Percentage gains in 11 
Vm correlated with percentage changes in iMVF (r = 0.527; P = 0.002) and 1-RM (r = 12 
0.482; P = 0.005) but not in explosive force (r ≤ 0.243; P ≥ 0.175). Percentage 13 
changes in iMVF, 1-RM, and explosive force did not correlate with percentage 14 
changes in agonist, antagonist or stabilizer sEMG (all P > 0.05). Percentage gains in 15 
p inversely correlated with percentage changes in normalized explosive force at 150 16 
ms after force onset (r = 0.362; P = 0.038). Conclusions: We have shown for the first 17 
time that muscle hypertrophy explains a significant proportion of the inter-individual 18 
variability in isometric and isoinertial strength gains following 12-wk elbow flexor 19 





The strength response to resistance training (RT) is known to vary considerably 24 
between previously untrained individuals (Erskine et al. 2010; Hubal et al. 2005). 25 
Considering that muscle size explains ~50% of the inter-individual variability in 26 
maximum strength in the untrained state (Kanehisa et al. 1994; Bamman et al. 2000; 27 
Fukunaga et al. 2001), it is surprising that muscle hypertrophy does not appear to 28 
account for the variance in strength gains following RT (Jones and Rutherford 1987; 29 
Davies et al. 1988). However, it is possible that neural adaptations, also known to 30 
occur with RT, could confound the contribution of hypertrophy to strength gains. In 31 
fact, the first 2-3 weeks of a RT program have been shown to cause rapid increases in 32 
strength that have been largely attributed to neural adaptations, while the contribution 33 
of muscle hypertrophy to strength gains is considered to be increasingly more 34 
important after these initial weeks (Moritani and deVries 1979; Seynnes et al. 2007). 35 
Therefore, the role of hypertrophy in explaining strength gains may be elucidated by 36 
considering the RT responses after the first weeks of RT, i.e. once neural adaptations 37 
have largely taken place. An initial phase of RT may also serve as a standardized 38 
period of physical activity, thus reducing the variability in training status [which 39 
might also affect the individual training responses (Kraemer et al. 2002)] prior to a 40 
more prolonged experimental period of RT.  41 
 42 
The contribution of muscle hypertrophy to strength gains may depend on the strength 43 
task assessed, e.g. isometric, isoinertial or explosive strength. Although it is well 44 
established that RT induces gains in both isometric and isoinertial strength 45 
(Rutherford and Jones 1986; Erskine et al. 2010; Folland et al. 2002), the effect of RT 46 
on explosive strength is controversial (Aagaard et al. 2002; Hakkinen et al. 1998; 47 
5 
Andersen et al. 2010; Tillin et al. 2011; Blazevich et al. 2009; Blazevich et al. 2008). 48 
A better understanding of the how specific physiological adaptations contribute to the 49 
individual improvements in isometric, isoinertial and explosive strength after RT may 50 
help to optimize RT, in order to elicit specific adaptations and functional outcomes, 51 
such as improved physical performance in athletic groups and a reduced risk of falling 52 
in older populations. 53 
 54 
In addition to neural and hypertrophic adaptations, RT is known to increase the 55 
muscle fascicle pennation angle (p), i.e. the angle at which the muscle fascicles insert 56 
into the aponeurosis (Aagaard et al. 2001; Erskine et al. 2010). Although an increase 57 
in p enables more contractile material to attach to the aponeurosis (leading to an 58 
increase in force output), there is a concomitant reduction in force resolved at the 59 
tendon due to the oblique line of pull of the fascicles (Alexander and Vernon 1975). 60 
Therefore, documenting inter-individual differences in p in response to RT may 61 
provide a more complete assessment of how morphological adaptations explain 62 
strength changes following RT.  63 
 64 
The aim of this study was to determine the contribution of muscle hypertrophy to the 65 
inter-individual differences in isometric, isoinertial and explosive strength changes in 66 
response to RT. An upper body elbow flexor RT model was used to maximize the 67 
hypertrophic response (Cureton et al. 1988; Welle et al. 1996), and changes in p were 68 
also assessed. The unique design of this study incorporated an initial 3-wk RT period 69 
to overcome neural adaptations and to standardize prior physical activity before 70 
participants completed a 12-wk experimental RT period. Changes in neuromuscular 71 
activation of the agonist, antagonist and stabilizer muscles were assessed by 72 
6 
normalizing surface EMG activity to appropriate reference measures in order to give 73 




Thirty-three healthy, recreationally active young men volunteered (mean ± SD: age, 78 
23.4 ± 3.0 yrs; height, 1.76 ± 0.06 m; body mass, 75.2 ± 10.7 kg) and provided 79 
written informed consent prior to their involvement in this 25-week study, which was 80 
approved by the Loughborough University Ethical Advisory Committee and 81 
conformed to the standards set by the 1964 Declaration of Helsinki. Health status and 82 
habitual physical activity were assessed using questionnaires and the physical activity 83 
rating was 2.6 ± 0.4, where 1 = extremely inactive and 5 = exceptionally active 84 
(Baecke et al. 1982). Volunteers were excluded from the study if they reported use of 85 
purported anabolic supplements in the previous 6 months, had a history of upper body 86 
exercise in the previous 12 months or were <18 or >30 yrs old.  87 
 88 
Study Overview 89 
Some of the muscle response data reported here have been published in a previous 90 
report investigating the effects of protein supplementation on the gains in muscle size, 91 
strength and architecture with RT (Erskine et al. 2012). As no differences between 92 
protein and placebo supplementation groups were observed regarding any of the 93 
training adaptations, the data have been collapsed across groups for the purpose of 94 
answering the current (long-standing and previously unresolved) research question, 95 
i.e. what is the contribution of muscle hypertrophy to strength changes following RT? 96 
In addition to the previously reported data, stabilizer surface EMG (sEMG) and 97 
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explosive force data have been included here to provide a more comprehensive 98 
account of the neuromuscular adaptations to chronic RT.   99 
 100 
The RT protocol and some of the pre and post-training measurements have been 101 
described in detail in the previously published study (Erskine et al. 2012). Therefore, 102 
they will be described briefly here. Thirty-three participants completed an initial 3-wk 103 
period of elbow flexor RT, which was followed by 6-wk of no training and then a 12-104 
wk period of experimental elbow flexor RT. The initial RT period provided extensive 105 
familiarization to the RT exercises and neuromuscular tests (data not reported here), 106 
whilst also standardizing participant training status and facilitating neural adaptations 107 
prior to the 12-wk experimental RT period. All RT involved exercising both arms. 108 
Three to 4 days before and after the 12-wk RT, strength [maximum isometric 109 
voluntary force (iMVF), single repetition maximum (1-RM) and explosive force], size 110 
[muscle volume and maximum anatomical cross-sectional area (ACSAmax)] and 111 
fascicle pennation angle (p) of the elbow flexor muscles were measured in the 112 
dominant arm. To determine whether neural adaptations did occur during the 12-wk 113 
RT (and to help differentiate neural from morphological contributions to strength 114 
gains), sEMG of the agonist, antagonist and stabilizer muscles was assessed during 115 
the three strength tasks and normalized to appropriate reference measures. All tests 116 
for each participant were performed at the same time of day before and after training.  117 
 118 
Resistance Training (RT) 119 
Participants performed 3 training sessions per week (Monday, Wednesday and 120 
Friday) during both RT periods. Each session comprised unilateral seated elbow 121 
flexion ‘preacher curls’ using dumbbells, with alternating sets using the dominant and 122 
8 
non-dominant arms, and then bilateral preacher curls on a resistance training machine 123 
(Body Solid, Forest Park, USA), with a 2 min rest between sets. The loading for both 124 
exercises was 8-10 RM and the load was increased when participants could lift 10 125 
reps during the final set of an exercise. The 3-wk RT involved 2 sets of each exercise, 126 
and this was the same for wk 1-2 of the 12-wk RT, but increased to 3 sets (unilateral) 127 
and 2 sets (bilateral) during wk 3-4 and 3 sets of both exercises for wk 5-12. 128 
Participant adherence was 100%, i.e. all participants performed 9 and 36 training 129 
sessions during the 3 and 12-wk RT periods, respectively.  130 
 131 
Pre and post RT neuromuscular measurements  132 
Unilateral single repetition maximum (1-RM) 133 
A series of incremental unilateral elbow flexion preacher curl lifts of a dumbbell were 134 
performed whilst seated on the same modified preacher bench that was used in 135 
training. After 10 warm-up reps at 40% 1-RM, 3 reps were performed at 80% 1-RM. 136 
Thereafter, a series of single lifts were performed with 1 min rest intervals at 137 
increments of +0.5 kg if the preceding lift was successful. The last successful lift was 138 
defined as 1-RM.  139 
 140 
Isometric maximum voluntary force (iMVF) 141 
Elbow flexor iMVF was measured using a custom-built strength-testing chair with the 142 
elbow joint angle set to 60° (0º = full elbow extension). The wrist was strapped to an 143 
S-Beam tension-compression load cell (Applied Measurements Ltd, Aldermaston, 144 
UK), which was positioned perpendicular to the direction of forearm movement 145 
during isometric elbow flexion/extension. The force signal was interfaced with an 146 
analog-to-digital converter (CED micro 1401, CED, Cambridge, UK), sampled at 2 147 
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kHz with a PC using Spike 2 software (CED, Cambridge, UK) and low-pass filtered 148 
(500 Hz edge frequency) with a second order Butterworth digital filter. Participants 149 
completed 4 isometric elbow flexion maximum voluntary contractions (MVCs), each 150 
lasting 3 s and separated by ≥30 s. Biofeedback and verbal encouragement were 151 
provided during and between each MVC. Participants then completed 4 isometric 152 
elbow extension MVCs with an identical protocol to determine the maximum sEMG 153 
(sEMGmax) amplitude of the TB (see below for details). Isometric MVF for elbow 154 
flexion and extension was the greatest instantaneous voluntary force achieved during 155 
that action.  156 
 157 
Isometric explosive contractions 158 
In addition to the MVCs detailed above, participants performed 10 isometric 159 
explosive voluntary elbow flexion contractions (each separated by 20 s). During each 160 
contraction participants attempted to flex their elbow as ‘fast and hard’ as possible 161 
(Sahaly et al. 2001), with emphasis on fast, for 1 s from a relaxed state, while 162 
achieving at least 80% iMVF. During each contraction, participants were instructed to 163 
avoid any countermovement (elbow extension prior to elbow flexion). A computer 164 
monitor displayed both force (on a sensitive scale around resting values) and the slope 165 
of the force-time curve. The latter was used to provide immediate biofeedback of 166 
performance, specifically peak rate of force development (RFD, 1 ms time constant) 167 
during each contraction, and the former highlighted any countermovement. The three 168 
contractions with the largest peak RFD and no discernible countermovement or pre 169 
tension (change of baseline force of < 0.5 N during the 100 ms prior to contraction 170 
onset) were used for analysis of the force signal. Analysis consisted of measuring 171 
force at 50, 100 and 150 ms from force onset and peak RFD (which typically occurred 172 
10 
at 60-70 ms after force onset). Force at all three time points and peak RFD are 173 
reported both in absolute terms and relative to iMVF. Force onset was identified 174 
manually as previously described (Tillin et al. 2010), i.e. by using constant y- and x-175 
axis scales of ~1 N and 500 ms, respectively. After placing the vertical cursor on the 176 
onset, the resolution was increased (y-axis scale: ~0.5 N; x-axis scale: 25 ms) to 177 
confirm the exact location of force onset, i.e. the apex of the last trough before the 178 
signal deflected from the baseline noise.  179 
 180 
Muscle hypertrophy 181 
The dominant arm was scanned using a Magnetom Symphony 1.5-T MRI scanner 182 
(Siemens AG, Erlangen, Germany) with the participant supine. Three overlapping T1-183 
weighted axial scans (time of repetition 420 ms; time to echo 1.2 s; matrix 284 x 448 184 
pixels; field of view 181 x 200 mm; slice thickness 10 mm; interslice gap 0 mm) were 185 
performed perpendicular to the humerus/radius from the acromion process to below 186 
the wrist. Reference markers (lipid capsules) were placed on the skin mid-way along 187 
the humerus and radius to ensure accurate reconstruction of the scans offline using a 188 
dicom image viewer (Osirix Foundation, Geneva, Switzerland). Thus, the relevant 189 
slice from the first scan was matched with the identical slice in the second scan, and 190 
so on. The anatomical cross-sectional area (ACSA) of each muscle of interest (biceps 191 
brachii, BB; brachialis, BRACH; brachioradialis, BR) was then manually outlined 192 
(excluding visible fat and connective tissue) and plotted against bone length. A spline 193 
curve was fitted to the ACSA data points of each muscle and volume was calculated 194 
as the area under the curve (Erskine et al. 2009); the sum of the three volumes 195 
provided total elbow flexor muscle volume. The largest ACSA (ACSAmax) was 196 
recorded for BB, BRACH and BR, and the sum of the three ACSAmax provided 197 
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ΣACSAmax.  198 
 199 
Muscle fascicle pennation angle (θp) 200 
BB short head (BBS) and BRACH θp was examined using B-mode ultrasonography 201 
(SSA-37OA Power Vision 6000, Toshiba, Otawara-Shi, Japan) with an 8 MHz linear-202 
array transducer. The participant lay supine with the dominant elbow fully extended 203 
and the shoulder abducted by 90°. Two millimeter-wide strips of ultrasound-absorbent 204 
tape (3M, Neuss, Germany) were placed perpendicular to the long axis of the BBS at 205 
50 mm intervals between the cubital crease and the shoulder, which formed markers 206 
on the sonographs and ensured that θp was analyzed at the same location pre and post 207 
RT. The probe was slowly glided in a straight line midway between the lateral and 208 
medial boundaries from the cubital crease to the proximal end of BBS (in line with 209 
the direction of the muscle fascicles). Individual frames were analyzed offline (NIH 210 
ImageJ, Bethesda, USA). Fascicle θp was determined in 3 BBS fascicles within 50 211 
mm of its distal end and in 3 BRACH fascicles within 50 mm of its proximal end. The 212 
mean of the 3 measurements determined θp for each muscle, and for each individual, 213 
the average of the θp for BBS and BRACH provided the mean elbow flexor θp.  214 
 215 
Surface electromyography (sEMG) activity 216 
Surface EMG activity was recorded from 2 agonists [the short and long heads of 217 
biceps brachii (BBS and BBL)], 1 antagonist [lateral head of triceps brachii (TB)] and 218 
2 stabilizers [anterior deltoid (AD) and pectoralis major (PM)] on the dominant side 219 
using 2 Delsys Bagnoli-4 sEMG systems (Delsys, Boston, USA). Following 220 
preparation of the skin (shaving, lightly abrading and cleansing with 70% ethanol), 221 
double-differential surface electrodes (1 cm inter-electrode distance, Model DE-3.1; 222 
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Delsys) were attached over each muscle using adhesive interfaces. BBS and BBL 223 
electrodes were placed mid-belly at a location that corresponded to 75% of the 224 
distance from the coracoid process to the medial epicondyle of the humerus, as this 225 
location is distal to the motor point region in each head (Lee et al. 2010). The TB 226 
electrode was placed over the distal third of the muscle, and the AD electrode was 227 
placed 5 cm distally from the acromion process over mid-sagittal plane. The PM 228 
electrode was placed at 50% of the distance from the medial end of the clavicle to the 229 
axilla, and reference electrodes were placed on the clavicle. All electrode locations 230 
(with regard to distances from anatomical landmarks) were measured and recorded for 231 
relocation during subsequent tests. Surface EMG signals were amplified (x100, 232 
differential amplifier 20-450 Hz) and sampled at 2 kHz with the same analogue to 233 
digital converter and PC as the force signal, prior to being band-pass filtered in both 234 
directions between 6-500 Hz using a 2
nd
 order Butterworth digital filter.  235 
 236 
The root mean square (RMS) of the sEMG signal over a 500 ms epoch around iMVF 237 
(± 250 ms) was used to assess activation of all muscles during elbow flexion iMVF. 238 
During the concentric phase of the 1-RM lift, the sEMG RMS of all muscles was 239 
assessed for the 200 ms period that gave the highest agonist sEMG RMS. During 240 
explosive contractions, the sEMG RMS from all muscles was determined in time 241 
periods of 0-50, 50-100 and 100-150 ms, from the onset of sEMG activity in the first 242 
agonist muscle to be activated. As with the onset of force, agonist sEMG onset was 243 
identified manually (Tillin et al. 2010), with the y- and x-axis scales set at 100 mV 244 
and 500 ms, respectively. The vertical cursor was placed on the onset and the scale 245 
was reduced to 50 mV and 25 ms for the y- and x-axis, respectively, to confirm the 246 
exact location of sEMG onset, i.e. the apex of the last peak/trough before the signal 247 
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deflected from the baseline noise. 248 
 249 
To further minimize the variability in sEMG RMS amplitude (Burden 2010; Tillin et 250 
al. 2011), recordings during all three elbow flexion strength tasks were normalized to 251 
an appropriate reference measurement: BBL and BBS to the evoked supramaximal 252 
compound muscle action potential (Mmax) in each head (see below for details); TB to 253 
TB sEMGmax [recorded over a 500 ms epoch around elbow extension iMVF (± 250 254 
ms)]; AD and PM to AD and PM sEMGmax (the highest sEMG RMS recorded over 255 
successive 500 ms periods) during a maximum isometric bench press (see below for 256 
details). The antagonist and stabilizer sEMG recordings during elbow flexion tasks 257 
were clearly sub-maximal and could therefore be normalised to the EMGmax of these 258 
muscles when acting as agonists (TB elbow extension; AD and PM bench press). 259 
Agonist (BBL and BBS) sEMG recordings during the elbow flexion tasks measured 260 
maximal volitional activation and thus for normalisation purposes an independent 261 
non-volitional reference was used (evoked Mmax). 262 
 263 
Evoked compound muscle action potential (M-wave) 264 
To elicit M-waves from BBL and BBS, the musculocutaneous nerve was electrically 265 
stimulated (DS7AH, Digitimer Ltd., Welwyn Garden City, UK) with single square 266 
wave pulses (0.2 ms duration). A self-adhesive electrode (5 x 5 cm; Verity Medical, 267 
Andover, UK) served as an anode and was attached to the skin over the central 268 
portion of the TB muscle. The cathode (1 cm diameter, Electro Medical Supplies, 269 
Wantage, UK) was held to the skin over the musculocutaneous nerve, in between the 270 
BBS and BBL, at 50% of the distance between the medial epicondyle of the humerus 271 
and the coracoid process [the motor entry point of the BB heads (Lee et al. 2010)]. 272 
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The precise location of the cathode was determined (within 3-5 attempts) as the 273 
position that evoked the greatest M-wave response for a particular submaximal 274 
electrical current (typically 30-50 mA). M-waves were evoked at 10-20 mA 275 
incremental current intensities until a plateau was achieved (typically 80-140 mA). 276 
Thereafter, the electrical current was increased by 20% and 3 supramaximal M-waves 277 
were evoked. Mmax was defined as the mean peak-to-peak sEMG response to these 3 278 
stimuli. 279 
 280 
Isometric bench press MVCs 281 
PM and AD sEMG activity was recorded during isometric incline bench press MVCs. 282 
The participant lay supine on a bench, with the ‘head end’ raised and placed on a 283 
portable force plate (Kistler Quattro Jump 9290AD, Winterhur, Switzerland), thus 284 
producing a 15º incline. Shoulders were abducted to 90º and the elbow angle was 90º, 285 
so that the forearms were perpendicular to a fixed horizontal bar positioned directly 286 
above the shoulders, while the feet were placed on the other end of the bench. Three 287 
isometric bench press MVCs were performed (30 s rest between each attempt) by 288 
pushing up against the immovable bar as hard as possible for 3 s. Verbal 289 
encouragement and biofeedback were provided during and after each MVC, and the 290 
highest sEMG, i.e. sEMGmax, for each stabilizer muscle was used for further analysis.  291 
 292 
Statistical analysis 293 
All data were analyzed by the same investigator. Pre and post-RT differences in 294 
iMVF, 1-RM, muscle size, and p were determined with paired t-tests. Changes in 295 
force and sEMG during explosive contractions were identified with repeated measures 296 
ANOVAs [within factor: training (pre/post RT); between factor: time (Force: 50, 100 297 
15 
and 150 ms; sEMG: 0-50, 50-100 and 100-150 ms)]. Relative changes in all variables 298 
were calculated as percentage change from pre- to post-RT for each individual. 299 
Relative changes in the size of the three individual elbow flexor muscles were 300 
compared using a one-way ANOVA, while relative changes in BB and BRACH p 301 
were compared with an independent t-test. Pearson correlations were used to 302 
determine the relationships between relative changes in morphological and neural 303 
adaptations and the three indices of strength. Where two physiological adaptations, 304 
i.e. muscle hypertrophy and baseline 1-RM, were found to correlate with the % 305 
change in 1-RM, a partial correlation was used to determine the contribution of 306 
muscle hypertrophy while controlling for baseline 1-RM. Significance was defined as 307 
P < 0.05 and group data are expressed as mean ± standard deviation (SD). 308 
 309 
RESULTS 310 
Pre-training relationships between muscle strength and size 311 
Pre-training iMVF was highly correlated with muscle volume (r = 0.812; P < 0.001) 312 
and ΣACSAmax (r = 0.806; P < 0.001). Similarly, 1-RM pre-training was strongly 313 
correlated with muscle volume (r = 0.768, P < 0.001) and ΣACSAmax (r = 0.787, P < 314 
0.001). Prior to the 12-wk RT period, explosive force production during the initial 315 
phase of contraction (50 ms) did not correlate with muscle volume (r = 0.219, P = 316 
0.21) or ΣACSAmax (r = 0.176, P =0.324), but these muscle size indices were 317 
increasingly correlated with explosive force production as the contraction progressed 318 
(100 ms: muscle volume r = 0.391, P = 0.024; ΣACSAmax r = 0.428, P = 0.013; 150 319 
ms: muscle volume r = 0.693, P < 0.001; ΣACSAmax r = 0.725, P < 0.001).  320 
 321 
Muscle strength changes after RT 322 
16 
Relative increases in iMVF and 1-RM were 13.2 ± 9.1 and 41.6 ± 19.9%, respectively 323 
(Table 1). Although absolute peak RFD did not change post 12-wk RT, peak RFD 324 
normalized to iMVF decreased by 9.5 ± 16.3% (Table 1). Absolute explosive force 325 
production at 50 ms after force onset was reduced after 12-wk RT (ANOVA, training 326 
P = 0.18; training x time P = 0.029; post-hoc t-test pre vs. post, P = 0.001), but there 327 
were no changes at 100 ms (t-test, P = 0.252) or 150 ms (t-test, P = 0.695; Fig. 1A). 328 
Explosive force normalized to iMVF was reduced at all 3 time points after force onset 329 
(ANOVA, training effect P < 0.001; group x training P = 0.449; post-hoc t-test pre vs. 330 
post all P < 0.001; Fig. 1B).  331 
 332 
Insert Table 1 here.  333 
 334 
Insert Fig. 1 here.  335 
 336 
Muscle size and architectural changes after RT 337 
Total elbow flexor muscle volume (+15.9 ± 6.0%), ΣACSAmax (+15.9 ± 5.8%) and p 338 
(+16.2 ± 7.5%) all increased following the 12-wk RT, and individual muscle 339 
responses are presented in Table 2. There were no significant differences between the 340 
relative hypertrophic responses of the individual elbow flexor muscles regarding 341 
muscle volume (1-way ANOVA, P = 0.189; Table 2), ACSAmax (1-way ANOVA, P = 342 
0.598; Table 2), or p (t-test, P = 0.354; Table 2). The individual relative increases in 343 
total elbow flexor muscle volume were unrelated to baseline muscle volume (r = 344 
0.055, P = 0.768), habitual physical activity levels (r = 0.134, P = 0.451). However, 345 
the relative changes in elbow flexor muscle volume (r = 0.429, P = 0.013) and 346 
ΣACSAmax (r = 0.464, P = 0.007) were correlated with the individual gains in elbow 347 
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flexor p. 348 
 349 
Insert Table 2 here. 350 
 351 
Neurological changes after RT 352 
At elbow flexion iMVF post 12-wkRT, normalized sEMG was unchanged after 12-wk 353 
RT in the agonists (t-test BBL, P = 0.167; BBS, P = 0.537; Table 3), antagonist (t-test 354 
P = 0.207; Table 3) and stabilizers (PM, t-test P = 0.151; AD, t-test P = 0.058; Table 355 
3). During the 1-RM, normalized sEMG did not change after 12-wk RT in the 356 
agonists (t-test, BBL, P = 0.788; BBS, P = 0.182; Table 3), or in the stabilizers (PM, 357 
t-test P = 0.074; AD, t-test P = 0.780; Table 3). However, normalized antagonist 358 
sEMG during 1-RM decreased by 4.7 ± 37.7% after 12-wk RT (t-test P = 0.029; 359 
Table 3). During explosive force production, there were no changes in agonist (BBL, 360 
ANOVA, training P = 0.093, training x time P = 0.583; BBS, ANOVA, training P = 361 
0.249, training x time P = 0.965), antagonist (TB, ANOVA, training P = 0.117, 362 
training x time P = 0.803), or stabilizer (PM, ANOVA, training P = 0.164, training x 363 
time P = 0.582; AD, ANOVA, training P = 0.221, training x time P = 0.720) 364 
normalized sEMG in any of the three time windows (0-50 ms, 50-100 ms and 100-365 
150 ms) after agonist sEMG onset.  366 
 367 
Insert Table 3 here.  368 
 369 
Physiological contributors to the strength changes after RT 370 
iMVF: Individual % changes in iMVF correlated with the relative changes in both 371 
total elbow flexor muscle volume (r = 0.527, P = 0.002; Fig. 2A) and elbow flexor 372 
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ΣACSAmax (r = 0.493, P = 0.004), but not with relative changes in p (r = 0.184, P = 373 
0.304). The relative changes in iMVF did not correlate with baseline iMVF (r = 374 
0.148, P = 0.416), habitual physical activity levels (r = 0.212, P = 0.239), or relative 375 
changes in normalized agonist (r = 0.187, P = 0.295), antagonist (r = 0.077, P = 376 
0.656), or stabilizer (r = 0.184, P = 0.307) sEMG at iMVF.  377 
 378 
1-RM: The individual % gains in 1-RM were inversely correlated with baseline 1-RM 379 
values (r = 0.519, P = 0.002; Fig. 2B). Changes in 1-RM were also positively 380 
correlated with relative gains in total elbow flexor muscle volume (r = 0.482, P = 381 
0.005; Fig. 2C) and elbow flexor ΣACSAmax (r = 0.406, P = 0.020). When controlling 382 
for baseline 1-RM, the correlations between changes in 1-RM and gains in total elbow 383 
flexor muscle volume (r = 0.435, P = 0.013) and changes in elbow flexor ΣACSAmax 384 
(r = 0.383, P = 0.031) were slightly weaker but still significant. However, relative 385 
changes in 1-RM did not correlate with normalized agonist, antagonist, or stabilizer 386 
sEMG during 1-RM (All r ≤ 0.155, P ≥ 0.389). Further, the relative changes in 1-RM 387 
were not related to the percentage gains in elbow flexor p (r = 0.205, P = 0.254). 388 
 389 
Insert Fig. 2 near here.  390 
 391 
Explosive strength: The individual relative changes in absolute and normalized 392 
explosive force at all three time points (r ≤ 0.243, P ≥ 0.175), and absolute and 393 
normalized peak RFD (r ≤ 0.190, P ≥ 0.292), were unrelated to the percentage 394 
changes in total elbow flexor muscle volume and ΣACSAmax. Percentage changes in 395 
absolute (All r ≤ 0.285, P ≥ 0.107) and normalized (All r ≤ 0.281, P ≥ 0.126) 396 
explosive force (at any time point after force onset) did not correlate with % changes 397 
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in normalized sEMG of any of the muscles investigated (at the appropriate time 398 
points). Percentage changes in p were, however, inversely correlated with the % 399 
change in normalized force at 150 ms (r = 0.362, P = 0.038) but not at 50 ms (r = 400 
0.089, P = 0.615) or 100 ms (r = 0.192, P = 0.284) after force onset.  401 
 402 
DISCUSSION 403 
We aimed to determine the contribution of elbow flexor muscle hypertrophy to the 404 
changes in isometric, isoinertial and explosive strength following 12-wk elbow flexor 405 
RT. By including an initial 3-wk RT period, we attempted to overcome neural 406 
adaptations prior to the experimental 12-wk RT intervention, and to highlight the role 407 
of muscle hypertrophy in explaining the inter-individual variability in strength gains. 408 
Based on the correlations between the change in muscle volume and changes in 409 
isometric and isoinertial strength, we have shown for the first time that RT-induced 410 
muscle hypertrophy explains substantial proportions of the inter-individual changes in 411 
isometric and isoinertial, but not explosive, strength.  412 
 413 
The individual percentage changes in muscle size and strength seen in our study were 414 
highly variable and comparable to previous studies that have investigated the 415 
variability in these training responses (Hubal et al. 2005; Erskine et al. 2010). In our 416 
study, the variable responses occurred after carefully controlling prior physical 417 
activity and RT status with a standardized 3-wk period of RT and 6-wk of no RT. The 418 
medium strength (Cohen 1992) correlations between the individual percentage 419 
changes in muscle volume and changes in maximum isometric and isoinertial strength 420 
suggest that muscle hypertrophy explained ~28% (R
2
 = 0.28) and ~23% (R
2
 = 0.23), 421 
respectively, of these strength gains. However, when baseline 1-RM values (another 422 
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predictor of 1-RM changes) were taken into account, the contribution of muscle 423 
hypertrophy to isoinertial strength gains was reduced to ~19% (R
2
 = 0.19), i.e. still a 424 
moderate effect size (Cohen 1992). This is the first report to document the 425 
contribution of muscle hypertrophy to individual strength gains following RT. Two 426 
previous reports found no relationship, although their findings may have been 427 
confounded by limited elbow flexor [+5.4 ± 3.4% (Davies et al. 1988)] and 428 
quadriceps femoris [+5.0 ± 4.6% (Jones and Rutherford 1987)] muscle hypertrophy. 429 
Furthermore, relatively low sample sizes (n = 12) and no prior RT period to overcome 430 
neural adaptations are probable reasons for the discrepancy in the findings of these 431 
studies compared to ours.  432 
 433 
Considering the strong relationships between muscle size (total volume and 434 
ΣACSAmax) and isometric and isoinertial strength at baseline in this study (All, r = 435 
0.77-0.81), which is in agreement with previous reports (Kanehisa et al. 1994; 436 
Bamman et al. 2000; Fukunaga et al. 2001), it is perhaps surprising that we did not 437 
find stronger relationships between the changes in muscle size and strength with RT. 438 
Despite strenuous efforts to minimize the test-retest variability of our measurements, 439 
resulting in high reproducibility (Erskine et al. 2012), any errors in the measurements 440 
of muscle strength and size, or discrepancies in the measurement of these variables, 441 
could confound their relationship. Additionally, assessing the changes that occur with 442 
RT involves measurements at two time points, which is likely to lead to a greater 443 
accumulation of measurement errors than cross-sectional assessments that rely on a 444 
single measurement. Furthermore, RT-induced hypertrophy shows a steady increase 445 
for the first 6 months and after the first 2 months, hypertrophy and isometric strength 446 
gains appear to increase in parallel (Narici et al. 1996). Therefore, it is possible that 447 
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the relationship between hypertrophy and strength changes might have been even 448 
stronger had the current RT period been of a longer duration. Moreover, based on 449 
these issues, it seems likely that muscle hypertrophy exerts a stronger influence on the 450 
changes in isometric and isoinertial strength than we have documented in this study. 451 
 452 
An alternative explanation for the weaker relationship between hypertrophy and 453 
strength changes (compared to the relationship at baseline) is that other physiological 454 
adaptations may be more important contributors to enhanced strength following RT. 455 
Regarding neural adaptations, we found only minor changes in neuromuscular 456 
activation: a small decrease in antagonist muscle co-activation during the 1-RM and 457 
no changes in agonist or stabilizer activation during any of the strength tasks. Thus, it 458 
would appear that the initial 3-wk RT period served its purpose in eliciting neural 459 
adaptations prior to the experimental 12-wk RT, and that neural changes played only a 460 
minor role in affecting strength changes following the 12-wk RT. However, it should 461 
be noted that sEMG does not distinguish between motor unit recruitment, 462 
synchronisation or firing rate. Therefore, it is possible that adaptations in one of these 463 
parameters may have been masked by the consistency, or even opposite changes, of 464 
the other parameters. Nevertheless, previous studies have reported high levels of 465 
elbow flexor muscle activation in the untrained state (Allen et al. 1998; Gandevia et 466 
al. 1998), with no increase in activation following RT (Herbert et al. 1998), thus 467 
suggesting a limited capacity for neural adaptation to RT in this muscle group.  468 
 469 
Another physiological factor that could have explained the inter-individual 470 
differences in strength responses to RT was an increase in muscle fascicle pennation 471 
angle (p), which is thought to occur in response to muscle fibre hypertrophy 472 
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(Aagaard et al. 2001). Theoretically, an increase in p leads to a trade-off between an 473 
increase in force from the hypertrophied muscle fibres, but a reduced transmission of 474 
force to the tendon due to the more oblique line of pull of the fascicles (Alexander and 475 
Vernon 1975). In fact, we found the changes in p to be positively related to 476 
hypertrophy (change in volume, r = 0.43; change in ΣACSAmax, r = 0.46), but were 477 
unrelated to any of the strength changes. The relative changes in p varied 478 
considerably from +5% to +35%, and might therefore have had a confounding effect 479 
on the relationship between hypertrophy and strength gains.  480 
 481 
The inverse relationship observed between baseline 1-RM and RT-induced changes in 482 
1-RM, although reported previously (Hubal et al. 2005), was surprising considering 483 
that we had standardized prior RT status and physical activity levels. Learning effects 484 
have been proposed to explain the large increases in the 1-RM after RT (Rutherford 485 
and Jones 1986), and could conceivably explain this relationship. However, the lack 486 
of any substantive changes in agonist, antagonist and stabilizer activation during the 487 
1-RM after RT in our study would argue against this possibility. Alternatively, inter-488 
individual differences in RT-induced changes in muscle fascicle length (Erskine et al. 489 
2010) could influence the length-tension relationship (Reeves et al. 2004), thus having 490 
a pronounced impact on the improvements in 1-RM.  491 
 492 
Although we have been able to demonstrate that muscle hypertrophy explains a 493 
significant proportion of the inter-individual variability in strength gains, a substantial 494 
amount of the variability remains unexplained. We acknowledge that our 495 
measurement of muscle size did not account for possible changes in non-contractile 496 
material, myofibrillar packing or muscle fibre-type composition, all of which could 497 
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have potentially influenced the muscle size-force relationship, and could therefore 498 
have confounded the relationship between hypertrophy and strength changes.  499 
 500 
Despite substantial increases in muscle size and iMVF after 12-wk RT, we found 501 
decreased absolute explosive force production at 50 ms and a reduced ability to 502 
express the available force generating capacity explosively, i.e. explosive force 503 
normalized to iMVF, during the first 150 ms of muscle contraction. This is in 504 
agreement with some previous work (Andersen et al. 2010; Tillin et al. 2011; 505 
Blazevich et al. 2009) but contrary to other reports (Aagaard et al. 2002; Hakkinen et 506 
al. 1998; Blazevich et al. 2008), and probably relates to the precise nature of the 507 
training stimulus (Tillin and Folland 2013). Although these changes were unrelated to 508 
muscle hypertrophy or neuromuscular activation, we did observe an inverse 509 
relationship between changes in θp and normalized explosive force measured at 150 510 
ms after force onset. All other factors remaining constant, an increase in θp serves to 511 
decrease the shortening velocity of the whole muscle, as the amount of whole muscle 512 
shortening is the product of muscle fascicle shortening and the cosine of θp (Narici 513 
1999). Thus, the greater the increase in θp, the lower the shortening velocity, leading 514 
to a reduction in RFD when normalized to iMVF. The fact that we saw this 515 
relationship only with changes in force measured at 150 ms after force onset could be 516 
due to the lower reliability of explosive force measured during the early phase of 517 
contraction (Buckthorpe et al. 2012). Alternatively, it may be that the early phase is 518 
more influenced by a reduction in the proportion of IIx muscle fibres (Andersen et al. 519 
2010), which have faster contractile properties than IIa fibres (Bottinelli et al. 1996; 520 
D'Antona et al. 2006; Larsson and Moss 1993).  521 
 522 
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In conclusion, we have demonstrated for the first time that muscle hypertrophy 523 
explains a significant proportion of the inter-individual variability in isometric and 524 
isoinertial strength changes in response to 12-wk elbow flexor RT. However, a large 525 
amount of the variability remains unexplained and, although changes in intramuscular 526 
force transmission, myofibrillar packing and fibre-type composition cannot be 527 
discounted, due to limitations with measuring muscle size and strength in vivo, we 528 
suspect that muscle hypertrophy accounts for a greater proportion of the inter-529 
individual variation in strength gains than reported here.  530 
 531 
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Table 1. Elbow flexor isometric, isoinertial and explosive strength before (Pre) and after (Post) 12-wk 
RT. Data are mean ± SD (n = 33).  
Strength variable Pre Post Change (%) Min (%) Max (%) 
iMVF (N) 262.3 ± 42.3 296.4 ± 50.5* +13.2 ± 9.1 -4.2  +36.4 
1-RM (kg) 12.8 ± 3.2 17.7 ± 3.7* +41.6 ± 19.9 +14.3  +90.3 
pRFD (N·s
-1
) 3766 ± 736  3800 ± 798 +2.0 ± 17.4 -33.3 +39.1 
pRFD (iMVF·s
-1
) 14.5 ± 2.3 13.0 ± 2.9 -9.5 ± 16.3% -40.2 +36.3 
iMVF, isometric maximum voluntary force; 1-RM, single repetition maximum; pRFD, peak rate of 
force development in absolute terms (N·s
-1
) and normalized (iMVF·s
-1
) to iMVF; *significantly 
different to Pre-RT (P < 0.0005).  
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Table 2. Elbow flexor muscle volume, maximum anatomical cross-sectional area (ACSAmax) and 
muscle fascicle pennation angle (p) before (Pre) and after (Post) the 12-wk RT period. Data are mean 
± SD (n = 33).  
Muscle variable Pre Post Change (%) Min (%) Max (%) 
Muscle volume (cm
3
)      
Biceps brachii  178.1 ± 31.9 208.7 ± 37.9* 17.3 ± 6.5 +5.9 +33.7 
Brachialis  153.3 ± 27.9 175.3 ± 33.2* 14.3 ± 6.3 +1.6 +33.1 
Brachioradialis  68.5 ± 14.7 79.5 ± 16.5* 16.5 ± 7.5 +3.7 +34.4 
Total elbow flexor 400.0 ± 66.7 463.6 ± 79.2* 15.9 ± 6.0 +5.0 +33.4 
ACSAmax (cm
2
)      
Biceps brachii  11.5 ± 2.1 13.5 ± 2.5* 16.9 ± 6.4 +6.6 +34.2 
Brachialis  12.0 ± 1.8 13.8 ± 2.1* 15.1 ± 6.6 +1.3 +32.5 
Brachioradialis  4.1 ± 0.8 4.8 ± 0.8* 16.0 ± 8.5 0.0 +35.1 
∑ACSAmax  27.7 ± 4.1 32.1 ± 4.8* 15.9 ± 5.8 +6.0 +33.6 
p (º)       
Biceps brachii 14.4 ± 2.8 16.8 ± 3.4* 17.2 ± 8.3 +5.0 +35.6 
Brachialis 10.8 ± 1.6 12.3 ± 1.6* 15.2 ± 9.0 +3.1 +35.6 
Mean elbow flexor 12.6 ± 1.4 14.6 ± 1.7* 16.2 ± 7.5 +4.5 +35.1 
*Significantly different to Pre-training (P < 0.0005).  
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Table 3. Normalized sEMG RMS amplitude at isometric elbow flexion maximum voluntary force 
(iMVF), during single repetition maximum lifts (1-RM), and during 0-50, 50-100 and 100-150 ms time 
periods after agonist sEMG onset before (Pre) and after (Post) 12-wk RT. Data are expressed relative to 
either Mmax (agonists: BBL and BBS), sEMGmax during elbow extension (antagonist: TB), or sEMGmax 
during incline bench press (stabilizers: PM and AD). Data are mean ± SD. 
                               Normalized sEMG (%) 
Strength Task  Agonists  Antagonist  Stabilizers 
            Pre/post RT BBL BBS  TB  PM AD 
iMVF         
Pre 9.3 ± 6.3 11.5 ± 9.3  14.3 ± 8.4  50.9 ± 20.2 44.9 ± 23.3 
Post 8.0 ± 3.8 10.5 ± 7.1  12.8 ± 7.8  55.4 ± 26.7 37.5 ± 23.1 
1-RM         
Pre 14.3 ± 8.2 14.7 ± 8.9  30.9 ± 21.0  55.1 ± 22.6 65.0 ± 27.3 
Post 14.0 ± 4.7 16.2 ± 9.1  26.0 ± 14.8*  62.2 ± 26.0 65.7 ± 27.5 
Explosive        
Pre 0-50 ms 5.0 ± 2.8 6.0 ± 3.4  7.3 ± 5.9  57.0 ± 43.0 43.5 ± 22.8 
Post 0-50 ms 4.8 ± 2.8 5.3 ± 3.0  6.9 ± 5.1  47.7 ± 30.5 41.3 ± 25.5 
Pre 50-100 ms 8.5 ± 5.9 9.8 ± 8.0  7.7 ± 6.0  51.2 ± 37.2 72.6 ± 40.2 
Post 50-100 ms 7.3 ± 3.5 8.7 ± 4.0  6.2 ± 4.9  50.8 ± 31.1 70.1 ± 33.6 
Pre 100-150 ms 8.2 ± 5.6 10.4 ± 7.2  7.3 ± 6.0  57.8 ± 40.5 66.9 ± 32.9 
Post 100-150 ms 6.9 ± 2.8 9.6 ± 5.8  6.0 ± 8.9  52.8 ± 30.3 58.6 ± 24.0 








Figure 1. Absolute (A) and normalized to iMVF (B) explosive force recorded at three time points (50, 
100 and 150 ms) after the onset of force (0 ms) before (○) and after (●) 12-wk RT; * significantly 
different from pre-training values (P < 0.05). 
 
Figure 2. The relationships between: the percentage changes in total elbow flexor muscle volume and 
iMVF (A; r = 0.527; P = 0.002); baseline 1-RM and percentage changes in 1-RM (B; r = 0.519; P = 
0.002); the percentage changes in total elbow flexor muscle volume and 1-RM (C; r = 0.482; P = 
0.005), after 12-wks elbow flexor RT.  
